Litigation Details for SANOFI-AVENTIS U.S. LLC v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2015)
✉ Email this page to a colleague
SANOFI-AVENTIS U.S. LLC v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-01-14 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-03-05 |
| Cause | 35:183 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 7,241,907 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SANOFI-AVENTIS U.S. LLC v. BRECKENRIDGE PHARMACEUTICAL, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SANOFI-AVENTIS U.S. LLC v. BRECKENRIDGE PHARMACEUTICAL, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-01-13 | 1 | expiration of U.S Patent Nos. 5,847,170 (“’170 patent”) and 7,241,907 (“’907 patent”) throughout the …The ’170 patent is owned by Aventis. 21. United States Patent No. 7,241,907 (the “’907… INFRINGEMENT OF U.S. PATENT NO. 7,241,907 38. Plaintiffs repeat… 47 U.S. Patent Jul. 10, 2007 US 7,241,907 B2 … US 7,241,907 B2 Didier et a]. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
